Published in Br J Pharmacol on November 01, 2002
Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine--searching for the connections. Br J Pharmacol (2012) 1.26
Small molecule microarrays enable the discovery of compounds that bind the Alzheimer's Aβ peptide and reduce its cytotoxicity. J Am Chem Soc (2010) 1.15
Alpha-helix targeting reduces amyloid-beta peptide toxicity. Proc Natl Acad Sci U S A (2009) 1.11
Discovery of amyloid-beta aggregation inhibitors using an engineered assay for intracellular protein folding and solubility. Protein Sci (2009) 1.03
Dye-binding assays for evaluation of the effects of small molecule inhibitors on amyloid (aβ) self-assembly. ACS Chem Neurosci (2012) 0.96
Small molecule inhibitors of amyloid β peptide aggregation as a potential therapeutic strategy for Alzheimer's disease. Acta Pharmacol Sin (2011) 0.93
Curcumin Pyrazole and its derivative (N-(3-Nitrophenylpyrazole) Curcumin inhibit aggregation, disrupt fibrils and modulate toxicity of Wild type and Mutant α-Synuclein. Sci Rep (2015) 0.86
Discovery and structure activity relationship of small molecule inhibitors of toxic β-amyloid-42 fibril formation. J Biol Chem (2012) 0.85
Keampferol-3-O-rhamnoside abrogates amyloid beta toxicity by modulating monomers and remodeling oligomers and fibrils to non-toxic aggregates. J Biomed Sci (2012) 0.84
Role of phosphodiesterase 5 in synaptic plasticity and memory. Neuropsychiatr Dis Treat (2008) 0.82
Aβ oligomer toxicity inhibitor protects memory in models of synaptic toxicity. Br J Pharmacol (2012) 0.79
Anti-amyloidogenic properties of some phenolic compounds. Biomolecules (2015) 0.78
Protection against β-amyloid-induced synaptic and memory impairments via altering β-amyloid assembly by bis(heptyl)-cognitin. Sci Rep (2015) 0.78
Profile of gantenerumab and its potential in the treatment of Alzheimer's disease. Drug Des Devel Ther (2013) 0.77
"Clicked" sugar-curcumin conjugate: modulator of amyloid-β and tau peptide aggregation at ultralow concentrations. ACS Chem Neurosci (2011) 0.77
Diverse molecular targets for therapeutic strategies in Alzheimer's disease. J Korean Med Sci (2014) 0.75
Alzheimer's disease: genes, proteins, and therapy. Physiol Rev (2001) 19.19
Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A (1998) 16.04
Neurotrophic and neurotoxic effects of amyloid beta protein: reversal by tachykinin neuropeptides. Science (1990) 6.03
Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum? Trends Neurosci (2001) 4.92
Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J Biol Chem (1999) 4.64
Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J Neurosci (1993) 4.60
Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy. Nat Med (1998) 4.17
Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J Biol Chem (1999) 3.20
Contrasting properties of two forms of long-term potentiation in the hippocampus. Nature (1995) 3.20
Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. J Neurochem (1997) 2.62
LTP mechanisms: from silence to four-lane traffic. Curr Opin Neurobiol (2000) 2.00
Suppression of mitochondrial succinate dehydrogenase, a primary target of beta-amyloid, and its derivative racemized at Ser residue. J Neurochem (1995) 1.65
Dendritic changes in Alzheimer's disease and factors that may underlie these changes. Prog Neurobiol (1998) 1.08
Beta-sheet breaker peptide inhibitor of Alzheimer's amyloidogenesis with increased blood-brain barrier permeability and resistance to proteolytic degradation in plasma. J Neurobiol (1999) 1.05
Optical recording of trisynaptic pathway in rat hippocampal slices with a voltage-sensitive dye. Neuroscience (1997) 0.96
Screening for pharmacologic inhibitors of amyloid fibril formation. Methods Enzymol (1999) 0.94
The acute neurotoxicity and effects upon cholinergic axons of intracerebrally injected beta-amyloid in the rat brain. Neurobiol Aging (1993) 0.94
Conformations of beta-amyloid in solution. J Neurochem (1997) 0.89
Treatment of Alzheimer's disease: rationale and strategies. Neurol Clin (2000) 0.82
Glutamate exacerbates amyloid beta1-42-induced impairment of long-term potentiation in rat hippocampal slices. Jpn J Pharmacol (2002) 0.82
Design and testing of inhibitors of fibril formation. Methods Enzymol (1999) 0.80
Deposition of soluble amyloid-beta onto amyloid templates: with application for the identification of amyloid fibril extension inhibitors. Methods Enzymol (1999) 0.80
Fatal attraction: nonself recognition and heterokaryon incompatibility in filamentous fungi. Eukaryot Cell (2003) 1.69
In vivo conversion of racemized beta-amyloid ([D-Ser 26]A beta 1-40) to truncated and toxic fragments ([D-Ser 26]A beta 25-35/40) and fragment presence in the brains of Alzheimer's patients. J Neurosci Res (2002) 1.16
Activation of T cell death-associated gene 8 regulates the cytokine production of T cells and macrophages in vitro. Eur J Pharmacol (2012) 0.99
Assignment of absolute configuration to SCH 351448 via total synthesis. Org Lett (2008) 0.95
Titanium(IV)-promoted Mukaiyama aldol-Prins cyclizations. Org Lett (2003) 0.94
Medium-chain fatty acid-sensing receptor, GPR84, is a proinflammatory receptor. J Biol Chem (2013) 0.91
A novel compound RS-0466 reverses beta-amyloid-induced cytotoxicity through the Akt signaling pathway in vitro. Eur J Pharmacol (2002) 0.87
Blockade of scavenger receptor class B type I raises high density lipoprotein cholesterol levels but exacerbates atherosclerotic lesion formation in apolipoprotein E deficient mice. J Pharm Pharmacol (2006) 0.86
Beta-amyloid racemized at the Ser26 residue in the brains of patients with Alzheimer disease: implications in the pathogenesis of Alzheimer disease. J Neuropathol Exp Neurol (2003) 0.84
Activation of T cell death-associated gene 8 attenuates inflammation by negatively regulating the function of inflammatory cells. Eur J Pharmacol (2011) 0.84
Troglitazone inhibits both post-glutamate neurotoxicity and low-potassium-induced apoptosis in cerebellar granule neurons. Brain Res (2002) 0.83
Structure-activity relationships of globomycin analogues as antibiotics. Bioorg Med Chem (2004) 0.83
beta-Amyloid-specific upregulation of stearoyl coenzyme A desaturase-1 in macrophages. Biochem Biophys Res Commun (2003) 0.83
Acute neuroinflammation exacerbates excitotoxicity in rat hippocampus in vivo. Exp Neurol (2002) 0.82
Development of an efficient therapeutic agent for Alzheimer's disease: design and synthesis of dual inhibitors of acetylcholinesterase and serotonin transporter. Chem Pharm Bull (Tokyo) (2010) 0.82
Glutamate exacerbates amyloid beta1-42-induced impairment of long-term potentiation in rat hippocampal slices. Jpn J Pharmacol (2002) 0.82
A novel compound, R-138329, increases plasma HDL cholesterol via inhibition of scavenger receptor BI-mediated selective lipid uptake. Atherosclerosis (2006) 0.82
Establishment of relative and absolute configurations of phaeosphaeride A: total synthesis of ent-phaeosphaeride A. J Org Chem (2015) 0.82
Pharmacological characterization of RS-1259, an orally active dual inhibitor of acetylcholinesterase and serotonin transporter, in rodents: possible treatment of Alzheimer's disease. J Pharmacol Sci (2003) 0.81
A conformational restriction approach to the development of dual inhibitors of acetylcholinesterase and serotonin transporter as potential agents for Alzheimer's disease. Bioorg Med Chem (2003) 0.79
RS-4252 inhibits amyloid beta-induced cytotoxicity in HeLa cells. Pharmacol Toxicol (2003) 0.78
Design, synthesis and structure-activity relationships of dual inhibitors of acetylcholinesterase and serotonin transporter as potential agents for Alzheimer's disease. Bioorg Med Chem (2003) 0.78
Amyloid beta-peptide alters the distribution of early endosomes and inhibits phosphorylation of Akt in the presence of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT). Brain Res Mol Brain Res (2002) 0.78
Design and optimization of novel (2S,4S,5S)-5-amino-6-(2,2-dimethyl-5-oxo-4-phenylpiperazin-1-yl)-4-hydroxy-2-isopropylhexanamides as renin inhibitors. Bioorg Med Chem Lett (2012) 0.78
Synthesis and antimicrobial activity of novel globomycin analogues. Bioorg Med Chem Lett (2003) 0.78
Target: tPA. Educational efforts help prehospital providers get stroke patients to the appropriate destinations and treatment. EMS Mag (2010) 0.78
Stereospecific construction of contiguous quaternary and tertiary stereocenters by rearrangement from indoline-2-methanol to 2,2,3-trisubstituted tetrahydroquinoline: application to an efficient total synthesis of natural virantmycin. Angew Chem Int Ed Engl (2003) 0.77
The stimulatory effects of caffeine with oseltamivir (Tamiflu) on light-dark behavior and open-field behavior in mice. Neurosci Lett (2009) 0.77
Identification of physiologically active substances as novel ligands for MRGPRD. J Biomed Biotechnol (2012) 0.77
Design and synthesis of dual inhibitors of acetylcholinesterase and serotonin transporter targeting potential agents for Alzheimer's disease. Org Lett (2002) 0.77
Vascular corticobasal syndrome caused by unilateral internal carotid artery occlusion. J Stroke Cerebrovasc Dis (2012) 0.75
[Hypothermia and memory disturbance as initial manifestations associated with lesions of the diencephalon in a patient with anti-aquaporin 4 antibody-associated disorder: a case report]. Rinsho Shinkeigaku (2014) 0.75
6-Ethyl-N,N'-bis(3-hydroxyphenyl)[1,3,5]triazine-2,4-diamine (RS-0466) enhances the protective effect of brain-derived neurotrophic factor on amyloid beta-induced cytotoxicity in cortical neurones. Pharmacol Toxicol (2003) 0.75
EBSTEIN ANOMALY IN THE TSUSHIMA LEOPARD CAT (PRIONAILURUS BENGALENSIS EUPTILURUS). J Zoo Wildl Med (2017) 0.75
Total synthesis of (+)-benzastatin E via diastereoselective Grignard addition to 2-acylindoline. Org Lett (2003) 0.75
Conformational analysis of globomycin with a signal peptidase II inhibitory activity using molecular dynamics simulation. Drug Des Discov (2003) 0.75
A novel compound, RS-1178, specifically inhibits neuronal cell death mediated by beta-amyloid-induced macrophage activation in vitro. Brain Res (2002) 0.75
Novel monoamine oxidase inhibitors, 3-(2-aminoethoxy)-1,2-benzisoxazole derivatives, and their differential reversibility. Jpn J Pharmacol (2002) 0.75
Respiratory tract committee, protocol composition committee, clinical trial committee, Japanese society of chemotherapy. J Infect Chemother (2002) 0.75
Meningitis with pneumocephalus originating from a sacral pressure ulcer. Intern Med (2013) 0.75
Kainate exacerbates beta-amyloid toxicity in rat hippocampus. Neurosci Lett (2003) 0.75
Caspase-independent cell death by Fas ligation in human thymus-derived T cell line, HPB-ALL cells. Microbiol Immunol (2007) 0.75
Improved preparation of methyl bis(2,2,2-trifluoroethoxy)-bromophosphonoacetate for the stereoselective synthesis of (E)-α-bromoacrylates. Chem Pharm Bull (Tokyo) (2012) 0.75